491 related articles for article (PubMed ID: 29274586)
1. Recent advances in the neurobiology and neuropharmacology of Alzheimer's disease.
Kumar K; Kumar A; Keegan RM; Deshmukh R
Biomed Pharmacother; 2018 Feb; 98():297-307. PubMed ID: 29274586
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
[TBL] [Abstract][Full Text] [Related]
3. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies.
Chen Y; Fu AKY; Ip NY
Pharmacol Ther; 2019 Mar; 195():186-198. PubMed ID: 30439458
[TBL] [Abstract][Full Text] [Related]
4. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
Saeedi M; Rashidy-Pour A
Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
[TBL] [Abstract][Full Text] [Related]
5. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Gugliandolo A; Bramanti P; Mazzon E
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
[TBL] [Abstract][Full Text] [Related]
6. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer disease therapeutics.
Irizarry MC; Hyman BT
J Neuropathol Exp Neurol; 2001 Oct; 60(10):923-8. PubMed ID: 11589422
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.
Castellani RJ; Lee HG; Perry G; Smith MA
Am J Alzheimers Dis Other Demen; 2006; 21(2):126-30. PubMed ID: 16634469
[TBL] [Abstract][Full Text] [Related]
9. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
11. The neurobiology and pharmacotherapy of Alzheimer's disease.
Felician O; Sandson TA
J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552
[TBL] [Abstract][Full Text] [Related]
12. Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis.
Teixeira JP; de Castro AA; Soares FV; da Cunha EFF; Ramalho TC
Molecules; 2019 Dec; 24(23):. PubMed ID: 31816853
[TBL] [Abstract][Full Text] [Related]
13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
14. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
Kalra J; Khan A
Eur J Pharmacol; 2015 Oct; 764():571-581. PubMed ID: 26209363
[TBL] [Abstract][Full Text] [Related]
15. Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease.
Castro A; Conde S; Rodriguez-Franco MI; Martinez A
Mini Rev Med Chem; 2002 Feb; 2(1):37-50. PubMed ID: 12369956
[TBL] [Abstract][Full Text] [Related]
16. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
17. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease: emerging trends in small molecule therapies.
Mohamed T; Rao PP
Curr Med Chem; 2011; 18(28):4299-320. PubMed ID: 21861820
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
Weinreb O; Amit T; Bar-Am O; Youdim MB
Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
[TBL] [Abstract][Full Text] [Related]
20. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]